Welch & Forbes LLC Edwards Lifesciences Corp Transaction History

Welch & Forbes LLC

$7.33 Billion
Q2 2024

A detailed history of Welch & Forbes LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Welch & Forbes LLC holds 245,921 shares of EW stock, worth $16.1 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

245,921

Previous 246,167 0.1%

Holding current value

$16.1 Million

Previous $23.5 Million 3.43%

% of portfolio

0.31%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$84.3 - $94.31 $20,737 - $23,200	-246 Reduced 0.1%	245,921 $22.7 Million
Q1 2024 May 02, 2024	SELL	$72.54 - $95.56 $816,945 - $1.08 Million	-11,262 Reduced 4.37%	246,167 $23.5 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $472,019 - $594,786	-7,649 Reduced 2.89%	257,429 $19.6 Million
Q3 2023 Nov 02, 2023	SELL	$69.28 - $93.38 $467,224 - $629,754	-6,744 Reduced 2.48%	265,078 $18.4 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $87,515 - $101,404	-1,075 Reduced 0.39%	271,822 $25.6 Million
Q1 2023 Apr 14, 2023	BUY	$74.26 - $84.51 $16,931 - $19,268	228 Added 0.08%	272,897 $22.6 Million
Q4 2022 Feb 02, 2023	SELL	$68.3 - $87.44 $327,293 - $419,012	-4,792 Reduced 1.73%	272,669 $20.3 Million
Q3 2022 Oct 28, 2022	BUY	$82.37 - $107.29 $117,624 - $153,210	1,428 Added 0.52%	277,461 $22.9 Million
Q2 2022 Jul 22, 2022	BUY	$86.5 - $128.27 $2.55 Million - $3.78 Million	29,497 Added 11.96%	276,033 $26.2 Million
Q1 2022 Apr 25, 2022	BUY	$101.96 - $128.34 $454,741 - $572,396	4,460 Added 1.84%	246,536 $29 Million
Q4 2021 Jan 19, 2022	SELL	$106.37 - $130.68 $356,339 - $437,778	-3,350 Reduced 1.36%	242,076 $31.4 Million
Q3 2021 Oct 13, 2021	BUY	$102.91 - $122.75 $32,416 - $38,666	315 Added 0.13%	245,426 $27.8 Million
Q2 2021 Jul 22, 2021	SELL	$83.84 - $104.76 $133,976 - $167,406	-1,598 Reduced 0.65%	245,111 $25.4 Million
Q1 2021 Apr 14, 2021	SELL	$78.68 - $90.67 $390,803 - $450,357	-4,967 Reduced 1.97%	246,709 $20.6 Million
Q4 2020 Jan 20, 2021	SELL	$71.69 - $91.23 $79,074 - $100,626	-1,103 Reduced 0.44%	251,676 $23 Million
Q3 2020 Oct 23, 2020	SELL	$67.19 - $87.44 $191,760 - $249,553	-2,854 Reduced 1.12%	252,779 $20.2 Million
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $9.69 Million - $13 Million	168,351 Added 192.88%	255,633 $17.7 Million
Q1 2020 Apr 17, 2020	SELL	$52.41 - $81.0 $143,498 - $221,778	-2,738 Reduced 3.04%	87,282 $16.5 Million
Q4 2019 Jan 17, 2020	SELL	$71.7 - $82.09 $26,744 - $30,619	-373 Reduced 0.41%	90,020 $21 Million
Q3 2019 Oct 11, 2019	SELL	$61.55 - $75.43 $25,358 - $31,077	-412 Reduced 0.45%	90,393 $19.9 Million
Q2 2019 Jul 12, 2019	SELL	$55.74 - $64.41 $84,780 - $97,967	-1,521 Reduced 1.65%	90,805 $16.8 Million
Q1 2019 Apr 29, 2019	SELL	$47.89 - $64.05 $178,773 - $239,098	-3,733 Reduced 3.89%	92,326 $17.7 Million
Q4 2018 Feb 05, 2019	SELL	$46.41 - $56.94 $55,691 - $68,328	-1,200 Reduced 1.23%	96,059 $14.7 Million
Q3 2018 Oct 17, 2018	SELL	$45.7 - $58.03 $71,429 - $90,700	-1,563 Reduced 1.58%	97,259 $16.9 Million
Q2 2018 Jul 16, 2018	SELL	$42.45 - $51.3 $275,288 - $332,680	-6,485 Reduced 6.16%	98,822 $14.4 Million
Q1 2018 Apr 12, 2018	SELL	$37.19 - $47.45 $22,685 - $28,944	-610 Reduced 0.58%	105,307 $14.7 Million
Q4 2017 Jan 26, 2018	SELL	$33.79 - $39.39 $171,146 - $199,510	-5,065 Reduced 4.56%	105,917 $11.9 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $4.03 Million - $4.31 Million	110,982	110,982 $12.1 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account